Atlas Trials

The Effect of a SGLT2 Inhibitor on Glucose Flux, Lipolysis and Exercise in Type 2 Diabetes

Clinical trial NCT04219124 · COMPLETED

Trial details

NCT number
NCT04219124
Sponsor
University of Leicester
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Type 2 Diabetes
Start date
2018-09-20
Primary completion
2020-01-08
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.